accountto split up a pharma company into mature and growth businesses. That strategy, however, ?remains hypothetical for large pharmaceutical companies,? the report says...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Moody's: Pharma Asset Sales Might Hurt Credit Quality
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account